Teva octreotide acetate 20 mg recalled over sterility assurance deficiencies
Teva is recalling nine lots of Octreotide Acetate for Injectable Suspension 20 mg after quality system deficiencies were identified during an FDA inspection at the contract manufacturer.
- Product
- OCTREOTIDE ACETATE — OCTREOTIDE ACETATE (OCTREOTIDE ACETATE)
- Category
- Drug
- Distribution
- Distributed nationwide